Regarding the NAWM, previous studies have reported the presence of gliosis in MS patients [42]; however, Graumann and colleagues (2003) did not observe significant differences in GFAP expression between the NAWM of MS patients and control subjects [43]. The gene discussed is GFAP; the disease is myeloid sarcoma.